Reference
Marzano AV, et al. Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study*. British Journal of Dermatology 184: 133-140, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/bjd.18983
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1847, 21 (2021). https://doi.org/10.1007/s40278-021-92578-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-92578-2